Skip to Main Content

Anemia

Chapter 66. Anemia

After the patient has been determined to have anemia, what laboratory parameter should subsequently be evaluated to aid in identifying macrocytic versus microcytic anemia?

A. Hct

B. MCV

C. Iron

D. Folic acid

The largest approved dose for a parenteral iron formulation is 750 mg. This is the maximum approved dose for which parenteral iron formulation?

A. Sodium ferric gluconate complex

B. Ferric carboxymaltose

C. Iron sucrose injection

D. Ferumoxytol injection

Typically anemia of chronic disease is characterized by which of the following?

A. Normocytic anemia and normal or increased ferritin

B. Microcytic anemia and decreased ferritin

C. Microcytic anemia and normal or increased ferritin

D. Normocytic anemia and decreased ferritin

What initial daily dose of folic acid is typically effective in treating anemia secondary to folic acid deficiency?

A. 100 mcg

B. 400 mcg

C. 1 mg

D. 4 mg

Which of the following is correct regarding the laboratory evaluation for anemia?

A. The CBC is the first laboratory test that should be conducted

B. Iron studies should be evaluated when the MCV is low

C. When the MCV is high folic acid and Vitamin B12 levels should be ordered

D. All of the above

Which of the following statements regarding ESAs is correct?

A. Clinical practice guidelines consider epoetin-α and darbepoetin-α to be therapeutic equivalents.

B. Clinical practice guidelines consider epoetin-α superior to darbepoetin-α because of superior efficacy.

C. Clinical practice guidelines consider darbepoetin-α superior to epoetin-α because of superior efficacy.

D. Clinical practice guidelines consider epoetin-α superior to darbepoetin-α because of superior toxicity profile.

Which of the following statements regarding ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.